• Home
  • Registration
    • Registration Information
    • Register
  • Committees
    • Scientific Committee
    • Discipline Advisory Committee
    • Organizing Committee
    • Research & Development Committee
  • Programme
    • Programme at a Glance
    • Scientific Programme
    • Workshop Programme
    • Keynote Speakers
    • Plenary Session Speakers
    • Discipline Invited Speakers
    • Workshop Speakers
    • Plenary Roundtable Speakers
  • Abstracts
    • Abstract Submission Guidelines
    • Submit an Abstract
  • Sponsors & Exhibitors
  • Travel & Accommodation
    • Congress Venue
    • Accommodation
    • Travel
  • Contact Us
  • Log Out  

  1. Home
Disciplines Invited Speakers Anatomical Pathology Chemical Pathology Haematology Human Genetics Immunology Microbiology Public Health Virology
Ms. Lynne Wilkinson
Medical Virology
Ms. Lynne Wilkinso
Prof Nicola Page
Medical Virology
Prof. Lenine Liebenberg
Dr. Marije Hofstral
Medical Virology
Dr. Marije Hofstra
Dr. Mazvita Muchengeti
Medical Virology
Dr. Mazvita Muchengeti
Dr. Daniel Morobadi
Medical Virology
Dr. Daniel Morobadi
Dr. Nicola Page
Medical Virology
Dr. Nicola Page
Prof. Leo Poon
Medical Virology
Prof. Leo Poon
Dr. Nishi Prabdial-Singh
Medical Virology
Dr. Nishi Prabdial-Singh
Dr.Sibongile Walazai
Medical Virology
Dr.Sibongile Walaza

Dr. Sibongile Walaza

Dr. Sibongile Walaza is a medical doctor with MSc in Epidemiology and biostatistics and a PhD in Public Health from the University of Witwatersrand, Johannesburg, South Africa. Her experience in public health and infectious diseases spans over 20 years. currently She is employed as the section head of the epidemiology team for the Centre for Respiratory Disease and Meningitis (CRDM) at the National Institute for Communicable Diseases (NICD) in South Africa. In this position, she is responsible for overseeing the implementation of surveillance and research programmes and for coordinating/managing/ training the teams conducting surveillance/research and responding to outbreaks that involve pathogens that cause respiratory diseases and meningitis. She is the principal investigator for the pneumonia surveillance and influenza-like illness (ILI) surveillance programmes. She has a joint appointment as a senior lecturer at the School of Public Health, University of the Witwatersand and has co-supervised a number of Msc students in the field of epidemiology. She has published over 125 peer-reviewed articles in the field of influenza and other respiratory illnesses. She has contributed to the development of guidelines for prevention and management of influenza in South Africa and is a member of several committees and working groups for National Department of Health and WHO

Prof. Leo Poon

Prof. Leo Poon, a virologist and public health scientist, received his doctoral training at the Sir William Dunn School of Pathology at the University of Oxford. He currently serves as a Chair Professor in the School of Public Health at HKU. He is also a co-director of HKU-Pasteur Research Pole at HKU, and HKJC Global Health Institute. Prof Poon is the Managing Director of C2i, an HKU InnoHK research centre. His lab is a WHO Reference Laboratory for several emerging infectious diseases (H5N1, COVID-19 and CoViNet).Professor Poon has published over 300 peer-reviewed articles. He has also been recognized as a Highly Cited Researcher since 2015. His research primarily focuses on emerging and re-emerging viruses that pose human health concerns, such as SARS-CoV, SARS-CoV-2, MERS-CoV and human/animal influenza viruses. He employs the "One Health" concept to study emerging viruses at the animal-human interface. In 2003, he was involved in the discovery of a novel coronavirus as the etiological cause of SARS, and he was among the first to decode the SARS coronavirus sequence. During the COVID-19 pandemic, he made significant contributions to our understanding of SARS-CoV-2 and applied these scientific findings to public health practices. Professor Poon serves as an expert for several international organizations and acts as an advisor for various task groups focused on infectious disease control within the WHO, FAO, and WOAH. He is also the Co-Editor-In-Chief of the Virology Journal.

Dr. Nicola Anne Page

Dr Nicola Anne Page (BSc(Agric) Microbiology (UP, cum laude), BSc(Agric) Hons Microbiology (UP), M(Med) Medical Virology (Medunsa), MPH Field Epidemiology (UP, cum laude), PhD Medical Virology (UL)) Nicola Page is a principal medical scientist, leading the Virology Division and currently acting head of the Centre for Enteric Diseases at the National Institute for Communicable Diseases. She also holds extra-ordinary professor positions within the Department of Medical Virology at the University of Pretoria. She is a registered medical scientist (Virology) with the Health Professionals Council of South Africa (HPCSA) and has a C1 National Research Foundation (NRF) rating. She serves as a member of the institutional biosafety and biosecurity committee and recently became a certified biosafety and biosecurity professional. She has authored or co-authored more than 70-refereed articles in scientific journals, worked on the WHO Manual of rotavirus detection and characterization and was a guest editor on the Journal of Infectious Diseases – Rotavirus in Africa supplement. She has presented numerous papers at national and international conferences and meetings and is a principal investigator on projects supported by national and international funding agencies. In addition, she has successfully supervised 16 post graduate students at Honours, Masters and PhD level. Her main research fields of interest are diarrhoeal diseases, the development of molecular techniques for the detection and characterization of pathogens associated with diarrhoea, the monitoring of rotavirus vaccine effectiveness, molecular epidemiology of enteric viruses, evaluation of new enteric vaccine candidates, and development of new data tools for studying the epidemiology of diarrhoea.

Ms. Lynne Wilkinson

Ms. Lynne Wilkinson is a technical consultant with International AIDS Society and a research associate with the University of Cape Town. Ms. Wilkinson has an MSc in Global Health and Development. She has been implementing HIV programs since 2005 predominantly in South Africa. She specializes in differentiated service delivery (DSD) across the HIV cascade and supports countries with DSD policy development including integration of service delivery components into clinical management. She co-authored the 2023 South African ART guidelines.

Prof. Lenine Liebenberg

Prof. Lenine Liebenberg is a Chief Researcher at the Centre for Epidemic Response and Innovation (CERI), Stellenbosch University. She leads the Immunology Research Programme that investigates the host-pathogen interactions so critical to designing biomedical interventions to prevent and control infections. Her expertise in immunology, microbiology, medical virology and genetics has furthered a profound research interest in controlling the spread of sexually transmitted infections (STIs), such as HIV and human papillomaviruses (HPV). Her research has developed the understanding of mucosal immune environments more permissive to sexually transmitted infections and has advised on alternative strategies and important considerations for designing more effective STI prevention interventions. She holds additional academic affiliations at the University of KwaZulu-Natal (UKZN) and the Centre of the AIDS Programme of Research in South Africa, also directing the training and academic degrees of students at Honours, Master’s and PhD levels.

Dr. Marije Hofstra

Dr. Marije Hofstra is a clinical microbiologist at the Centre for Epidemic Response and Innovation (CERI) at Stellenbosch University. She received her medical and clinical microbiology training at the University Medical Center Utrecht in the Netherlands. She completed the clinical scholars research training program of Harvard Medical School and holds a PhD in Medicine from the University Utrecht. Marije has been involved in HIV research for >10 years, focusing on clinical and public health implications of HIV drug resistance in different settings in Europe, the Caribbean and South Africa. She joined CERI in 2023, where she works on innovative molecular techniques for genomic surveillance and infectious disease diagnostics.

Dr. Nishi Prabdial-Sing

Dr. Nishi Prabdial-Sing is employed as a Principal Medical Scientist and head of Centre for Vaccines and Immunology (CVI), National Institute for Communicable Diseases (NICD). She has obtained a PhD degree in medical virology from the School of Pathology, University of Witwatersrand (WITS) in 2011. Thus far, she has successfully supervised and mentored several postgraduate students. She was awarded a C2 NRF-rating in 2020 and currently, has 30 peer-reviewed journal publications. She is focused on integrating testing and surveillance platforms for viral hepatitis. Since 2008, she is a member of the technical working group (TWG) on the compilation of the National Guidelines for the management of Viral Hepatitis with the South African National Department of Health (NDoH). Currently, she is a member of Federation of the Infectious Diseases societies of Southern Africa (FIDSSA), World Hepatitis Alliance, Royal Society of Medicine, UK and International Network on Health and Hepatitis in Substance Users (INHSU).

Dr. Mazvita Muchengeti

Dr Mazvita Muchengeti is the Head of Department, National Cancer Registry (NCR) of South Africa, National Institute for Communicable Diseases (NICD), National Health Laboratory Service (NHLS). Head of International Agency for Research on Cancer – Global Initiative for Cancer Registry development (IARC-GICR) Centre of Expertise, Johannesburg, South Africa. (MBChB, Postgraduate Diploma in HIV Management, MSc Epidemiology & Biostatistics, PhD). Dr Mazvita Muchengeti is the Head of Department at the National Cancer Registry of South Africa, at the NICD, NHLS and also leads the IARC-GICR Centre of Expertise in Johannesburg, South Africa within the African Cancer Registry Network. Her work focuses on cancer surveillance, cancer epidemiological research, capacity building and cancer policy development in African populations. She is a senior lecturer at Wits School of Public Health and a research associate at the South African Centre for Epidemiological and Modelling Analysis (SACEMA), Stellenbosch University.

Dr. Danie, Morobadi

Dr. Daniel Morobadi originates from Ga-Rankuwa. He completed his undergraduate studies in 2005 at the then Medunsa, now Sefako Makgatho Health Sciences University. He did his internship at Groote Schuur and Red Cross Children’s hospitals in Cape Town. He then completed his postgraduate studies at the University of Pretoria in 2014, obtaining an MMed degree in Medical Virology and FC Path Fellowship in Virology from the College of Medicine SA. Dr Morobadi joined Ampath after working for the National Health Laboratory Services as a consultant Pathologist in Virology at NHLS Universitas, Bloemfontein. He enjoyed teaching and training Medical Technology students, undergraduate and postgraduate Medical students at the University of the Free State where he currently serves as an affiliated lecturer. Dr Morobadi is passionate about life and personal development and makes it a point to SMILE at everyone regardless. He enjoys cooking and reading in his spare time and also loves gardening and working with my hands.

Quick Links
  • NHLS
  • NICD
  • NIOH
Congress Details
Dates:

02 - 05 October 2025

Venue:

Emperors Palace Convention Centre, JHB

Tags
  • Contact Us
  • Venue
  • Congress Venue
  • Accommodation
  • Maps
Other
  • Register

Copyright ©2025 NHLS. All Rights Reserved



Forgot Username or Password


Already Registered? Login


Login

Forgot Username or Password?



Register




Already Registered? Login


Complete Registration


Don't have an Account? Register

Disclaimer

By registering for PathReD Congress 2025, you are providing the congress organisers with your personal information, including but not limited to your name, contact details, and other relevant information. This information will be used for the purpose of congress administration and follow-ups related to the event. The congress organisers may also access your information stored in other databases belonging to the National Health Laboratory Service (NHLS) for the purpose of ensuring the accuracy and completeness of the information provided. Your personal information will be treated as confidential and will not be disclosed to any third party in accordance with the requirements of the Protection of Personal Information Act 4 of 2013 (POPIA), except as may be required by law.